Antigen-Specific Immunomodulation: CAAR-T cells Redefine Precision Therapy in Pemphigus Vulgaris
Journal of Cellular Immunology · 14.04.2026 · 8 (1) · 11
DOI: 10.33696/immunology.8.248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Immunology, online erschienen am 14.04.2026. Verfasst von Huijie Yuan und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Current therapies for antibody-mediated autoimmune diseases largely rely on broad immunosuppression or lineage-wide B-cell depletion. These approaches are associated with increased risks of infection and other adverse effects. This commentary focuses on Chimeric Autoantibody Receptor (CAAR) T-cell technology as a precision immunotherapy that selectively eliminates pathogenic autoreactive B-cell clones while preserving protective immunity. Using Pemphigus Vulgaris (PV) as a representative model, CAAR-T cells engineered to express desmoglein 3 (Dsg3) demonstrate antigen-specific targeting of B cells expressing anti-Dsg3 B cell receptors. Notably, these cells maintain cytolytic efficacy despite high circulating autoantibody titers and show tissue selectivity, sparing keratinocytes, potentially due to biophysical constraints governing immune synapse formation. We further discuss key translational challenges, including manufacturing complexity, the presence of additional pathogenic antibody populations (e.g., anti-Dsg1), and long-term cellular persistence. Collectively, CAAR-T technology represents a mechanistically distinct and potentially scalable therapeutic paradigm for antibody-mediated autoimmune disorders, emphasizing antigen-specific immune editing over global immune suppression.
Zitieren
APA
Yuan, H., Zhao, L., & Mao, X. (2026). Antigen-Specific Immunomodulation: CAAR-T cells Redefine Precision Therapy in Pemphigus Vulgaris. Journal of Cellular Immunology, 8(1), 11. https://doi.org/10.33696/immunology.8.248
Vancouver
Yuan H, Zhao L, Mao X. Antigen-Specific Immunomodulation: CAAR-T cells Redefine Precision Therapy in Pemphigus Vulgaris. Journal of Cellular Immunology. 2026;8(1):11. doi:10.33696/immunology.8.248
BibTeX
@article{Yuan2026,
author = {Yuan, Huijie and Zhao, Luhan and Mao, Xuming},
title = {Antigen-Specific Immunomodulation: CAAR-T cells Redefine Precision Therapy in Pemphigus Vulgaris},
journal = {Journal of Cellular Immunology},
year = {2026},
volume = {8},
number = {1},
pages = {11},
doi = {10.33696/immunology.8.248}
}
EUVIMED